Skip to main content

Table 3 Risk factors for 90-day mortality in the overall population (patients where BAL was performed, n = 85)

From: Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study

 Univariate analysis (n = 85)Multivariate analysis (n = 85)
OR95% CIp valueOR95% CIp value
Characteristics
 Age > 55 years1.241.02–1.5< 0.051.020.82–1.20.87
 BMI10.97–1.020.94   
 Serum albumin, g/L0.990.97–1.010.4   
 Glucocorticoid treatment1.150.95–1.40.16   
 HIV infection0.740.52–0.950.020.80.82–1.20.87
Bronchoalveolar lavage (BAL)
 Alveolitis profile of BAL0.750.61–0.920.0070.790.65–0.960.02
 Neutrophils1.020.99–1.040.12   
 Macrophages1.010.99–1.040.21
 Lymphocytes0.970.94–0.990.06
Co-infection
 Bacterial1.20.95–1.60.13   
 Viral1.251.02–1.520.031.20.99–1.40.07
 Invasive fungal1.210.76–1.90.41   
Blood tests
 White blood cell counts10.99–10.69   
 Polynuclear neutrophils1.070.8–1.40.76   
 Lymphocytes0.950.8–1.40.62   
 Serum CRP10.99–10.24   
Severity
 SAPS211–1.010.008   
 SOFA score1.081.05–1.1< 0.00011.051.02–1.090.0002
 Severe SDRA1.381.14–1.7< 0.0001   
 P/F ratio > 2000.780.64–0.96< 0.05   
  1. Italics characters correspond to the analysis parameters with a statistically significant difference
  2. BMI, body mass index; SAPS2, simplified acute physiology score version 2, SOFA score, sequential organ failure assessment score; HIV, human immunodeficiency virus